MEDXF
Medexus Pharmaceuticals Inc

240
Loading...
Loading...
Medexus Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products and treatment solutions focusing on therapeutic areas of oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. The firm products include IXINITY, Rasuvo, Metoject, Rupall, and Gleolan. The company was founded in 2003 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
91

Frequently Asked Questions

What is Market Cap of Medexus Pharmaceuticals Inc?
What is the 52-week high for Medexus Pharmaceuticals Inc?
What is the 52-week low for Medexus Pharmaceuticals Inc?
What is Medexus Pharmaceuticals Inc stock price today?
What was Medexus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Medexus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Medexus Pharmaceuticals Inc?
What is the 50-day moving average of Medexus Pharmaceuticals Inc?
How many employess does Medexus Pharmaceuticals Inc has?

Latest MEDXF News

View
No MEDXF news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.